Keywords: BSA; Bovine serum albumin; TBST; Tris buffered saline with 0.1% Tween-20; PVDF; Polyinylidene difluoride; DTT; Dithiothreitol; Epidermal Growth Factor Receptor variant III; Recombinant expression; Baculovirus expression;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AEX; anion exchange chromatography; CID; collision induced dissociation; DHB; 2,5-dihydroxybenzoic acid; ECD; electron capture dissociation; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; EGFRvIII; epidermal growth factor receptor v
Keywords: Glioblastoma; Treatment; Review; Pharmacology; Targeted therapy; Stem cell; AKT; protein kinase B; BBB; blood-brain barrier; BCNU; carmustin; CCNU; lomustin; c-MET; hepatocyte growth factor receptor; EGF(R); epidermal growth factor (receptor); EGFRvIII; e
Identification and suppression of epidermal growth factor receptor variant III signaling in fibroblast-like synoviocytes from aggressive rheumatoid arthritis by the mimotope
Keywords: EGFR; Epidermal Growth Factor Receptor; EGFRvIII; EGFR variant III; FLS; fibroblast-like synoviocytes; RA; rheumatoid arthritis; CFA/IFA; complete Freund adjuvant/incomplete Freund adjuvant; LEMIA; linked EGFR mimotope-induced antibodies; CPIA; the contro
Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line
Keywords: CUR; Curcumin; NPs; Nanoparticles; PLGA NPs; Poly (D, l-lactic-co-glycolic acid) Nanoparticles; CUR-PLGA NPs; Curcumin loaded PLGA Nanoparticles; PEMA; Poly(ethylene-alt-maleic anhydride); PVA; Polyvinyl alcohol; FITC; Fluorescein isothiocyanate; Blank PL
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
Recruitment of RNA molecules by connexin RNA-binding motifs: Implication in RNA and DNA transport through microvesicles and exosomes
Keywords: Cxs; connexins; Cx26; connexin26; Cx43; connexin43; CL; cytoplasmic loop; CTD; C-terminal domain; EGFRvIII; epidermal growth factor receptor variant III; E1-E2; extracellular loops; GJs; gap junctions; GJIC; gap junction intercellular communication; MVs;
Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps
Keywords: CAIX; Carbonic anhydrase IX; CAR; Chimeric antigen receptor; EGFR; Epidermal growth factor receptor; EGFRvIII; Epidermal growth factor receptor variant III; HSV-tk; Herpes simplex thymidine kinase; IDO; Indoleamine 2,3 dioxygenase; IL; Interleukin; MHC; M
The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III
Keywords: EGFR; epidermal growth factor receptor; EGFRvIII; epidermal growth factor receptor variant III; HCC; hepatocellular carcinoma; 5-FU; 5-fluorouracil; DPYD; dihydrouracil dehydrogenase; OPRT; orotate phosphoribosyltransferase; TS; thymidylate synthase; Epid
Rapid biochemical synthesis of 11C-labeled single chain variable fragment antibody for immuno-PET by cell-free protein synthesis
Keywords: PET; positron emission tomography; EGFRvIII; epidermal growth factor receptor variant III; scFv; single chain Fv; l-[methyl-11C]methionine; [11C]Met; CT; computed tomography; [18F]FDG; 2-[18F]-fluoro-2-deoxy-d-glucose; MWCO; molecular weight cut-off; Cell
Increased transforming growth factor-β2 in epidermal growth factor receptor variant III-positive glioblastoma
Keywords: Epidermal growth factor receptor variant III; Glioblastoma multiforme; Interleukin-10; Transforming growth factor-β2
Identification of an Exon 4-Deletion Variant of Epidermal Growth Factor Receptor with Increased Metastasis-Promoting Capacity
Keywords: de4 EGFR; the exon 4 deletion variant of EGFR; EGFR; epidermal growth factor receptor; EGFRvIII; epidermal growth factor receptor variant III; ERK; extracellular signal-regulated kinase; EGFRwt; wild type EGFR;
The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas
Keywords: Epidermal growth factor receptor variant III; Epidermal growth factor receptor; Cancer vaccine; Immunotherapy; Glioblastoma multiforme;
Passive Antibody-Mediated Immunotherapy for the Treatment of Malignant Gliomas
Keywords: Monoclonal antibody; Epidermal growth factor receptor variant III; Epidermal growth factor receptor; Tenascin-C; Bevacizumab; Glioblastoma multiforme;
c-Myc is required for transformation of FDC-P1 cells by EGFRvIII
Keywords: wtEGFR; wild-type growth factor receptor; EGFRvIII; epidermal growth factor receptor variant III; tTA; tetracycline-regulated transactivator protein; siRNA; small interfering RNA; VEGF2R; vascular endothelial growth factor receptor; EGFRvIII; c-Myc; Trans